Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 11Genitourinary 11Breast 11Other solid neoplasm 9Gastrointestinal 8Thoracic 7Head & Neck 6Lymphoid 5Gynecologic 4Dermatologic 4Tumor-Agnostic 3CNS 3Sarcoma 1Plasma cell 1Other 1Myeloid 1

Conditions

Melanoma 2Uveal Melanoma 1Spondylitis, Ankylosing 1Psoriasis 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Carcinoma, Basal Cell 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1

Interventions

pembrolizumab 69Nivolumab 57Ipilimumab 36Specimen Handling 32Magnetic Resonance Spectroscopy 25Cyclophosphamide 23Biopsy 18cemiplimab 14fludarabine 13relatlimab 11binimetinib 11Opdualag 11CTLA-4 Antigen 11trametinib 10fludarabine phosphate 10Radiosurgery 10avelumab 9Radiotherapy 9lifileucel 8dabrafenib 8Blood Specimen Collection 8atezolizumab 7aldesleukin 7Paclitaxel 7encorafenib 6X-Rays 6Standard of Care 6Interleukin-2 6Immunoglobulin G 6HhAntag691 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Practice Guidelines as Topic × Dermatologic × 90 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
200 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06075589 2026-03-19

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
108 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡